DEFINITION OF AN IMMUNODOMINANT T-CELL EPITOPE CONTAINED IN THE ENVELOPE GP41 SEQUENCE OF HIV-1

被引:0
|
作者
BELL, SJD
COOPER, DA
KEMP, BE
DOHERTY, RR
PENNY, R
机构
[1] UNIV NEW S WALES,NATL CTR HUMAN IMMUNODEFICIENCY VIRUS EPIDEMIOL & CLIN RES,SYDNEY,NSW,AUSTRALIA
[2] ST VINCENTS INST MED RES,MELBOURNE,AUSTRALIA
[3] FAIRFIELD HOSP,NATL CTR HUMAN IMMUNODEFICIENCY VIRUS VIROL,MELBOURNE,AUSTRALIA
[4] FAIRFIELD HOSP,MACFARLANE BURNET CTR MED RES,MELBOURNE,AUSTRALIA
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1992年 / 87卷 / 01期
关键词
HIV CONSERVED SEQUENCE; T-CELL EPITOPES; B-CELL EPITOPES; SYNTHETIC PEPTIDE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The majority of the immunodominant amino acid sequences of HIV-1 that have been characterized to date are coded for by hypervariable gene sequences. These variable sequences are however interspersed with sequences that are highly conserved between HIV strains. Immunogenic viral products with amino acid sequences that vary minimally between strains, and that consistently elicit both humoral and cellular immune responses, may be ideal for inclusion in a subunit vaccine. We studied HIV-seronegative and HIV-infected persons, classified as asymptomatic (AS), ARC or AIDS. Initially, we assessed the cellular immune status of each subject from results of T cell phenotype analyses, assays for serum levels of surrogate markers of disease progression, and responses to mitogens and recall antigen. In addition, we tested whether three short synthetic peptides derived from the conserved sequences of the envelope gp120 (aa 262-284) and gp41 (aa 579-601), and core p17 (aa 106-125) regions of the HTLV-IIIB isolate, could elicit B cell as well as T cell responses in HIV-infected subjects. Only the gp41-derived sequence was immunogenic at both B and T cell levels. To further characterize the gp41 epitope, we used a series of overlapping synthetic peptides derived from a conserved region of the envelope gp41 (aa 572-613). We thus identified an immunodominant 12-mer peptide sequence, gp41{8}(aa 593-604), which consistently elicited both T cell blastogenic and B cell (antibody) responses in AS HIV-seropositive individuals but not in ARC and AIDS patients. Linear regression analysis showed that in AS persons there was a strong positive correlation (P < 0.0005) between the absolute CD8+ T cell numbers and the magnitude of blastogenic responses to the gp41{8}(aa 593-604). Furthermore, those AS subjects with T cells that proliferated in response to this gp41 analogue also had significantly greater serum levels of antibody to the same short peptide sequence than symptomatic ARC and AIDS patients. These results suggest that cellular responses to the immunodominant and highly conserved envelope sequences of HIV-1, associated with increased CD8+ T cells, may be important in the pathogenesis of HIV disease.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 50 条
  • [41] Comparative evaluation of the TRUGENE HIV-1 envelope (gp41) genotyping assay on clinical samples
    Cabrera, C
    Marfil, S
    Poveda, E
    Puig, T
    Bonjoch, A
    Ziermann, R
    Soriano, V
    Clotet, B
    Ruiz, L
    ANTIVIRAL THERAPY, 2005, 10 (04) : S48 - S48
  • [42] Comparative evaluation of the TRUGENE HIV-1 envelope (gp41) genotyping assay on clinical samples
    Cabrera, C
    Marfil, S
    Poveda, E
    Puig, T
    Bonjoch, A
    Ziermann, R
    Soriano, V
    Clotet, B
    Ruiz, L
    ANTIVIRAL THERAPY, 2005, 10 : S48 - S48
  • [43] HIV-1 gp41 and gp160 are hyperthermostable proteins in a mesophilic environment - Characterization of gp41 mutants
    Krell, T
    Greco, F
    Engel, O
    Dubayle, J
    Dubayle, J
    Kennel, A
    Charloteaux, B
    Brasseur, R
    Chevalier, M
    Sodoyer, R
    El Habib, R
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (08): : 1566 - 1579
  • [44] Hydrogen peroxide for disulfide bridge formation in peptides with the immunodominant epitope sequences of HIV gp41 glycoproteins
    Sidorova, MV
    Kudryavtseva, EV
    Antopolskii, ML
    Palkeeva, ME
    Ovchinnikov, MV
    Bespalova, ZD
    BIOORGANICHESKAYA KHIMIYA, 1996, 22 (04): : 273 - 279
  • [45] HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
    Pan, Chungen
    Liu, Shuwen
    Jiang, Shibo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (02) : 94 - 105
  • [46] HIV-1 gp41 and TCRα Trans-Membrane Domains Share a Motif Exploited by the HIV Virus to Modulate T-Cell Proliferation
    Cohen, Tomer
    Cohen, Shmuel Jaffe
    Antonovsky, Niv
    Cohen, Irun R.
    Shai, Yechiel
    PLOS PATHOGENS, 2010, 6 (09)
  • [47] LLP-2 Domain on the Cytoplasmic Terminal Tail (CTT) of HIV-1 GP41 affects T-Cell but not HIV Virion Membranes
    Boscia, Alexander L.
    Akabori, Kiyotaka
    Benamram, Zachary
    Michel, Jonathan A.
    Steckbeck, Jonathan D.
    Jablin, Michael S.
    Montelaro, Ronald C.
    Nagle, John F.
    Tristram-Nagle, Stephanie
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 247A - 247A
  • [48] Biological function of HIV-1 transmembrane protein gp41 - A study on a putative cellular receptor of gp41
    Chen, YH
    Dierich, MP
    CHINESE SCIENCE BULLETIN, 1998, 43 (19): : 1630 - 1635
  • [50] REGULATION OF CELL-SURFACE LEVELS OF THE HIV-1 ENV PROTEIN BY AN INTERNALIZATION SIGNAL SEQUENCE IN GP41
    SILICIANO, RF
    ROWELL, JR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 198 - 198